ClinicalTrials.gg
RecruitingNCT06718296Updated Apr 27, 2026

Development of the Photographic Shoulder Scale

An observational study in Shoulder Pain, sponsored by Istanbul University - Cerrahpasa. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-04-27.

Sponsored by Istanbul University - Cerrahpasa · Observational

How we know

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 64 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 15 studies in Shoulder Pain by Istanbul University - Cerrahpasa — 3 open to participants now, 3 under way, none of them phase 3. Shoulder Pain · Istanbul University - Cerrahpasa.

Started
2024
with 1 other
Observational
2 of 15
1 open now
Registered
13th of 15
by date

Among the 15 studies in Shoulder Pain by Istanbul University - Cerrahpasa, this one is one of 2 that started in 2024, is one of 2 observational ones, and was the 13th registered.

Shoulder Pain

738 studies on the registry are indexed under Shoulder Pain; 168 are open to participants now.

Browse Shoulder Pain studies →

Open to participants now

3 of the 15 studies in Shoulder Pain by Istanbul University - Cerrahpasa are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 90 Shoulder Pain studies recruiting now, 25 (28%) set no upper age limit and 55 (61%) stop at 75 or younger; 3 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 64 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Shoulder Pain by Istanbul University - Cerrahpasa, or all of them as a file.
02

Study summary

Shoulder pain is a common cause of musculoskeletal complaints that affects home and work activities, as well as quality of life. It is the third most common musculoskeletal issue after spinal and knee pathologies. The prognosis for individuals with shoulder pain can vary, with approximately 50% still reporting symptoms six months after seeking primary care. In addition to pain, functional limitations can occur, interfering with work, hobbies, and social or sports activities. A large group of patients report persistent shoulder pain with a high rate of sick leave. As a result, the total economic cost associated with shoulder pain also becomes a significant concern.

The most frequently reported clinical pathologies associated with chronic shoulder pain are rotator cuff disorders, adhesive capsulitis, and glenohumeral osteoarthritis, which collectively constitute the largest portion of all shoulder pain pathologies. Patient-reported outcome measures (PROMs) are often used to assess functional loss and disability in patients. These outcome measures provide evidence about patients' perceptions of treatment and offer data on the long-term effectiveness of interventions. For this purpose, many shoulder-specific questionnaires have been developed.

Developing a tool that uses photographs representing activities to measure how much patients struggle with daily life activities could be an important alternative for shoulder patients. An example of such a scale is the Photograph Series of Daily Activities-Short Electronic Version (PHODA-SeV), which was developed for low back pain. A different photographic scale has also been developed to assess avoidance behavior in patients with shoulder pain. Similarly, developing a specific photographic scale to assess daily life activities in patients with shoulder pain could be useful in clinical practice, as it would help patients better understand the scope of the questions.

Read the detailed description

The aim of our study is to develop a photographic scale that includes daily life activities involving the shoulder to assess pain and function in patients with shoulder pain. Additionally, the study aims to evaluate the structural validity and internal consistency of the developed scale.

Hypotheses:

H0: The Photographic Shoulder Scale is not valid and reliable for individuals with shoulder pain.

H1: The Photographic Shoulder Scale is valid and reliable for individuals with shoulder pain.

In the research methodology, a Patient Information Form will be used to evaluate demographic and clinical information, along with the Photographic Shoulder Scale developed by us. Additionally, the ASES (American Shoulder and Elbow Surgeons) Scale will be used to assess shoulder pain and function, the Quick DASH scale will be used to measure the level of disability and functional limitations, and the SF-12 Scale will be used to assess quality of life.

Developing a specific photographic scale to assess daily life activities in patients with shoulder pain could be useful in clinical practice for helping patients understand the scope of thequestions. This scale could contribute to identifying the difficulties in daily activities caused by shoulder pain and assist clinicians in developing treatment plans. It may also help in identifying the disability in daily life activities due to shoulder pain.

03

Conditions studied

  • Shoulder Pain

Browse trials for

Keywords

  • Shoulder Pain
  • Photographic Assessment
  • Shoulder Pain Assessment Scale
04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals who are being followed at the Orthopedics and Traumatology Department of Başakşehir Çam and Sakura City Hospital and meet the inclusion criteria will be included in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals with traumatic or non-traumatic shoulder pain lasting for more than 3 months

Exclusion criteria

Exclusion Criteria:

  • Individuals with neurological and/or rheumatological diseases
  • Active local or systemic infections
  • A history of cancer
  • Severe visual impairments
  • Patients with traumatic conditions awaiting surgery
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Target follow-up
7 Days
Patient registry
Yes

Groups and cohorts

  • Study group

    All individuals participating in the study will sign an 'Informed Consent Form', and they will be informed about what they need to do as part of the study, what situations may arise, and any questions they have will be addressed. In the research methodology, a Patient Information Form will be used to evaluate demographic and clinical information. The ASES Scale will be used to assess shoulder pain and function, the Quick DASH will be used to measure the level of disability and functional limitations, and the SF-12 Scale will be used to assess quality of life. All scales applied to the patients will be completed within one day. The re-test of the Photographic Shoulder Scale will be conducted 7 days later. Individuals who are being followed at the Orthopedics and Traumatology Department of Başakşehir Çam and Sakura City Hospital and meet the inclusion criteria will be included in the study.

06

What researchers measure

Primary outcomes

  1. Photographic Shoulder Scale

    In the rehabilitation of the upper extremity musculoskeletal system, a 4-person team consisting of physiotherapists and orthopedists with theoretical and practical experience has prepared 30 activities consisting of movements commonly used in daily life. The team asked 3 specialists, "How important do you think it is to ask patients with shoulder pain about this activity?" and removed activities that the specialists deemed inappropriate, resulting in 16 activities. Photos were taken for these activities, and a scale consisting of 16 photos was applied as a pilot test to a group of 15 patients with shoulder pain. A question was asked, "Does this photo represent the activity as described?" Feedback on the topic was gathered. A scale was also added for pain assessment, using a rating from 0 to 10. The designed scale consists of two sections: the first section assesses pain, and the second section contains photo-based questions measuring daily life activities.

    Time frame: 1 day

Secondary outcomes

  1. Quick DASH

    It was designed to differentiate and assess the physical disability and symptoms in patients with musculoskeletal disorders of the upper extremity. The primary component of the questionnaire, Quick DASH, consists of 11 items, each of which is rated on a 5-point ordinal scale (17). To calculate the total DASH score, all responses are summed and averaged. This value is then subtracted by 1, multiplied by 25, and provides a total score between 0-100 (with 100 being the worst score).

    Time frame: 1 day

  2. SF-12

    The Short Form 12 (SF-12) scale will be used to assess health-related quality of life. The SF-12 is a shortened version of the SF-36 Health Quality Scale. It consists of 2 components: physical and mental health. The scale includes 12 questions that assess physical, social, and mental health. A higher score indicates a better state of health and improved quality of life, while a lower score indicates a deterioration in health.

    Time frame: 1 day

  3. ASES

    The ASES (American Shoulder and Elbow Surgeons) Scale consists of two sections: pain and functionality. The pain assessment includes one question, while the functionality assessment consists of 10 questions. The pain question is rated from 0 (no pain) to 10 (the worst pain imaginable). The functionality questions use a four-point Likert scale, ranging from 0 (cannot do) to 3 (not difficult). The total score ranges from 0 to 100.

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Crookes T, Wall C, Byrnes J, Johnson T, Gill D. Chronic shoulder pain. Aust J Gen Pract. 2023 Nov;52(11):753-758. doi: 10.31128/AJGP-04-23-6790. PubMed 37935145 ↗
  • Sousa CO, Nascimento JDS, Pozzi F, Kardouni JR, Michener LA. Shoulder Performance Activity Test (SPAT) for People With Shoulder Pain: Feasibility, Reliability, and Validity. Phys Ther. 2023 Mar 3;103(3):pzad006. doi: 10.1093/ptj/pzad006. PubMed 37172131 ↗
  • Ansanello W, Dos Reis FJJ, Tozzo MC, Zatiti SCA, Meulders A, Vlaeyen JWS, de Oliveira AS. Development of the Avoidance Daily Activities Photo Scale for Patients With Shoulder Pain. Phys Ther. 2022 Feb 1;102(2):pzab268. doi: 10.1093/ptj/pzab268. PubMed 34935976 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2024 (actual). Primary completion is estimated for Sep 2026, 20 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 1, 2024
First posted
Dec 5, 2024
StartActual
Dec 15, 2024
Primary completionEst.
Sep 1, 2026
CompletionEst.
Dec 1, 2027
Last update
Apr 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06718296
Responsible party
Tulay Ulku SEVIM (Master's degree graduate, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Dec 5, 2024
Start date
Dec 15, 2024
Primary completion
Sep 1, 2026 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Apr 27, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion